about
1,5-Disubstituted benzimidazoles that direct cardiomyocyte differentiation from mouse embryonic stem cells.Synthesis and SAR of b-annulated 1,4-dihydropyridines define cardiomyogenic compounds as novel inhibitors of TGFβ signaling.Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm.Chemical genetics and its potential in cardiac stem cell therapy.Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors.Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyogenesis in embryonic stem cellsPeptidomimetic small-molecule compounds promoting cardiogenesis of stem cells.Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2.Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.Heart regeneration: opportunities and challenges for drug discovery with novel chemical and therapeutic methods or agents.Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.Effect of hypoxia on human adipose-derived mesenchymal stem cells and its potential clinical applications.Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt responseTransient Mesp1 expression: a driver of cardiac cell fate determination.TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies.
P2860
Q27325108-C05F6706-B7FB-4C2F-9300-DC9DAAA131AAQ30529635-EB299BCA-FB24-4550-9B96-4C1404A7207CQ33954234-EB71DD26-9AE2-421E-A3CB-84BA87536880Q34183137-1C52D931-7E50-4435-A38B-0D069803BF06Q34289899-2B102B59-1866-4528-84F3-3A5E876A687FQ34292182-CF31F839-73B2-4DD5-A239-1539E22C98D8Q34501443-0575D9A7-4493-4A29-A4B7-E2702459B18AQ36650882-5AFBE839-1E83-40A5-AB1A-5AA655203354Q38027106-1F277EAD-9555-4DC4-948F-871562F8E0DCQ38182522-2A08CCA0-E28C-4C3D-B777-E6D817B239ABQ38654054-C6AFAB69-0A06-47EE-9BD8-9309DBBF5D29Q38754669-2F3D0310-47DB-442E-9A28-2C5A6FBC19E7Q39423997-E225A9EC-E13C-4F82-A5FC-897B1F70F904Q40205062-2C058C94-DD08-40FA-89CB-76F3E5A56EFDQ42031459-12D86204-562D-4BFA-A151-E7D015566736
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A chemical biology approach to myocardial regeneration.
@en
A chemical biology approach to myocardial regeneration.
@nl
type
label
A chemical biology approach to myocardial regeneration.
@en
A chemical biology approach to myocardial regeneration.
@nl
prefLabel
A chemical biology approach to myocardial regeneration.
@en
A chemical biology approach to myocardial regeneration.
@nl
P2093
P2860
P1476
A chemical biology approach to myocardial regeneration
@en
P2093
Erik Willems
Frederick Lo
John Cashman
Marion Lanier
Mark Mercola
P2860
P2888
P304
P356
10.1007/S12265-011-9270-6
P407
P50
P577
2011-03-22T00:00:00Z